Remark(s)
|
deletion of an integral number of tandem 3.3 kb repeats, D4Z4 associated exclusively with 4qA allele (in the region distal to D4Z4), with hypomethylation of D4Z4 (also in FSHD with unaltered D4Z4), may be a nuclear enveloppe disorder (changes in the DNA-protein interactions at the nuclear envelope affecting signaling pathway)
DUX4-containing D4Z4 elements are present at high and variable copy number on 4q35 with 11 to >100 repeats in controls, but in FSHD, one allele is reduced in size to 1-10 repeats, which is accompanied by a change in chromatin packaging into a less repressive state (PMID: 21110847))
proximal unit of D4Z4 is significantly hypomethylated in affected and asymptomatic carriers, while in type-2 FSHD, a form of the disease that is not linked to contractions of D4Z4 repeats at 4q35, both alleles are significantly hypomethylated (PMID: 19339494))
may be caused by transcriptional dysregulation of multiple genes, in cis and in trans, different in affected patients compared to asymptomatic related carriers (PMID: 19339494))
specific loss of histone H3 lysine 9 trimethylation and CBX3/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD) (PMID: 19593370))
represents the first human disease to be associated with the incomplete developmental silencing of a retrogene array (DUX4) normally expressed early in development (PMID: 21060811))
current genetic signature of FSHD is a common polymorphism and only half of FSHD probands carry this molecular signature (PMID: 22482803))
fetuses carrying an FSHD-linked genotype have an extensive dysregulation of several muscle-specific and 4q35 genes at early development stage at a distance from any muscle defect (PMID: 23777630))
modifier role for SMCHD1 in FSHMD1A, and carriers of the FSHMD1A allele without the SMCHD1 mutation were only mildly affected (PMID: 24075187)) |